JETEMA, Co., Ltd. (KOSDAQ:216080)

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022
Period Ending	Dec 31, 2023	Dec 31, 2022
Medical Products	58.72B	45.99B
Medical Products Growth	27.66%	-
Total	58.72B	45.99B
Total Growth	27.66%	-

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022
Period Ending	Dec 31, 2023	Dec 31, 2022
South Korea	58.72B	45.99B
South Korea Growth	27.66%	-
Total	58.72B	45.99B
Total Growth	27.66%	-

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 9, 2026

Data Sources Report a data error